Previous close | 235.95 |
Open | 236.59 |
Bid | 233.80 x 200 |
Ask | 234.01 x 100 |
Day's range | 233.64 - 237.53 |
52-week range | 204.44 - 261.54 |
Volume | |
Avg. volume | 467,628 |
Market cap | 11.005B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 11.80 |
EPS (TTM) | 19.81 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 292.25 |
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 26, 2024--Please replace the photo for release dated April 24, 2024 with the accompanying corrected photo.
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.